AGIGEN
Live / Applied — Revived — awaiting further action (as of 22 Oct 2025)
What this means for you
Not registered yet, but its 01 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98022737
- Mark type
- Stylized text
- Filed
- 01 Jun 2023
- Published for opposition
- 02 Apr 2024
Goods and services
- Class 001 — Chemicals: Cells for scientific and research use; Cells for scientific, laboratory or medical research; Diagnostic preparations for scientific or research use; Diagnostic reagents for scientific or research use; Enzymes for scientific and research purposes; Nucleotides for scientific and research use; Reagents for scientific and research use; Reagents for scientific or medical research use; Stem cells for research or scientific purposes
- Class 005 — Pharmaceuticals: Vaccines; Medical diagnostic reagents for the analysis of body fluids; Vaccines for human use; Adjuvants for use with vaccines; Therapeutic vaccines
- Class 042 — Scientific and technological services: Scientific research; Scientific research and development; Scientific research for medical purposes in the field of immunology; Scientific research for medical purposes in the field of aging and age-related disease; DNA screening for scientific research purposes; Drug screening for scientific research purposes; Genetic testing for scientific research purposes; Medical and scientific research in the field of immunology; Medical and scientific research in the field of aging and age-related disease; Medical and scientific research information in the field of immunology; Medical and scientific research information in the field of aging and age-related diseases; Providing information about medical and scientific research; Providing medical and scientific research information; Research and development of vaccines; Research and development of vaccines and medicines
- Class 044 — Medical, beauty and agricultural services: Medical analysis services relating to the treatment of patients; Medical analysis for the diagnosis and treatment of persons; Performing diagnosis of diseases
Owner
- McLaughlin Research Institute, Great Falls, MT, US
- McLaughlin Research Institute, Great Falls, MT, US
- Tiffany Hensley-McBain, Great Falls, MT, US
- Tiffany Hensley-McBain, Great Falls, MT, US
Prosecution history
- 08 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Oct 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 22 Oct 2025 — NOTICE OF REVIVAL - E-MAILED
- 22 Oct 2025 — PETITION TO REVIVE-GRANTED
- 22 Oct 2025 — TEAS PETITION TO REVIVE RECEIVED
- 16 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Nov 2024 — SOU EXTENSION 1 GRANTED
- 08 Nov 2024 — SOU EXTENSION 1 FILED
- 08 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2024 — PUBLISHED FOR OPPOSITION
- 13 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED